Rigel Pharmaceuticals (RIGL) FCF Margin Growth (3y) (2015 - 2026)
Rigel Pharmaceuticals (RIGL) FCF Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn | 1,988.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,988.00 |
| Dec 31, 2025 | 7,605.00 |
| Sep 30, 2025 | 9,092.00 |
| Jun 30, 2025 | 7,321.00 |
| Mar 31, 2025 | 15,286.00 |
| Dec 31, 2024 | 11,626.00 |
| Sep 30, 2024 | 8,778.00 |
| Jun 30, 2024 | -20,756.00 |
| Mar 31, 2024 | 765.00 |
| Dec 31, 2023 | 7,305.00 |
| Sep 30, 2023 | 10,197.00 |
| Jun 30, 2023 | 10,563.00 |
| Mar 31, 2023 | -862.00 |
| Dec 31, 2022 | 2,780.00 |
| Sep 30, 2022 | 1,378.00 |
| Jun 30, 2022 | 11,667.00 |
| Mar 31, 2022 | -15,007.00 |
| Dec 31, 2021 | -12,165.00 |
| Sep 30, 2021 | 36,741.00 |
| Jun 30, 2021 | 175,723.00 |